The global Biopharmaceutical Excipients Market, which was valued at USD 2.7 billion in 2023, is projected to reach an impressive USD 4.17 billion by 2031, growing at a Compound Annual Growth Rate (CAGR) of 5.6% during the forecast period from 2024 to 2031. This substantial growth is driven by the burgeoning demand for innovative drug delivery systems, increased...